NIH Guide: Weekly Index for March 26, 2021

Funding Opportunities

• NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
  (PAR-21-143)
  National Human Genome Research Institute
  Application Receipt Date(s): August 8, 2021; December 8, 2021; April 8, 2022; August 8, 2022; December 8, 2022; April 8, 2023; August 8, 2023; December 8, 2023; April 8, 2024; August 8, 2024; December 2, 2024 All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
  (PAR-21-166)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
  (PAR-21-183)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
  (PAR-21-206)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
  (PAR-21-208)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed)
  (PAR-21-212)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed)
  (RFA-AG-22-009)
  National Institute on Aging
  Application Receipt Date(s): October 4, 2021 - . No late applications will be accepted for this Funding Opportunity Announcement.
• Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)
  (RFA-AG-22-010)
  National Institute on Aging
  Application Receipt Date(s): October 4, 2021. No late applications will be accepted for this Funding Opportunity Announcement.
• Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)
  (RFA-AT-21-006)
  National Center for Complementary and Integrative Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  (RFA-CA-21-036)
  National Cancer Institute
  Application Receipt Date(s): August 6, 2021
• Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed
  (RFA-FD-21-030)
  Food and Drug Administration
  Application Receipt Date(s): May 24, 2021, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• AAV Vector manufacturing for diseases affecting very small populations (R01) Clinical Trials Not Allowed
  (RFA-FD-21-034)
  Food and Drug Administration
  Application Receipt Date(s): May 28, 2021, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Recompetition of the Pediatric Scientist Development Program (PSDP) (K12 Clinical Trial Not Allowed)
  (RFA-HD-22-006)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 29, 2021
• NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)
  (RFA-LM-21-001)
  National Library of Medicine
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
  (RFA-MD-21-004)
  National Institute on Minority Health and Health Disparities
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): Multiple dates, see announcement.
• Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
  (RFA-RM-21-021)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): May 28, 2021
• Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
  (RFA-RM-21-022)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): May 28, 2021
• Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)
  (RFA-TW-21-001)
  John E. Fogarty International Center
  National Institute on Aging
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional)
  (RFA-TW-21-002)
  John E. Fogarty International Center
  National Institute on Aging
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Application Receipt Date(s): July 8, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.